ARIPIPRAZOLE ORALLY DISINTEGRATING and ANXIETY

1,681 reports of this reaction

2.1% of all ARIPIPRAZOLE ORALLY DISINTEGRATING reports

#6 most reported adverse reaction

Overview

ANXIETY is the #6 most commonly reported adverse reaction for ARIPIPRAZOLE ORALLY DISINTEGRATING, manufactured by Accord Healthcare, Inc.. There are 1,681 FDA adverse event reports linking ARIPIPRAZOLE ORALLY DISINTEGRATING to ANXIETY. This represents approximately 2.1% of all 79,930 adverse event reports for this drug.

Patients taking ARIPIPRAZOLE ORALLY DISINTEGRATING who experience anxiety should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

ANXIETY1,681 of 79,930 reports

ANXIETY is a less commonly reported adverse event for ARIPIPRAZOLE ORALLY DISINTEGRATING, but still significant enough to appear in the safety profile.

Other Side Effects of ARIPIPRAZOLE ORALLY DISINTEGRATING

In addition to anxiety, the following adverse reactions have been reported for ARIPIPRAZOLE ORALLY DISINTEGRATING:

Other Drugs Associated with ANXIETY

The following drugs have also been linked to anxiety in FDA adverse event reports:

ABACAVIR SULFATEACETAMINOPHEN AND IBUPROFENACETAMINOPHEN, CAFFEINEACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCLACETAMINOPHEN, DEXTROMETHORPHAN HBRACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCLACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCLACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DIPHENHYDRAMINE HCLACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATEADAPALENE AND BENZOYL PEROXIDEADENOSINEALBUTEROLALISKIREN HEMIFUMARATEALPRAZOLAM

Frequently Asked Questions

Does ARIPIPRAZOLE ORALLY DISINTEGRATING cause ANXIETY?

ANXIETY has been reported as an adverse event in 1,681 FDA reports for ARIPIPRAZOLE ORALLY DISINTEGRATING. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is ANXIETY with ARIPIPRAZOLE ORALLY DISINTEGRATING?

ANXIETY accounts for approximately 2.1% of all adverse event reports for ARIPIPRAZOLE ORALLY DISINTEGRATING, making it a notable side effect.

What should I do if I experience ANXIETY while taking ARIPIPRAZOLE ORALLY DISINTEGRATING?

If you experience anxiety while taking ARIPIPRAZOLE ORALLY DISINTEGRATING, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

ARIPIPRAZOLE ORALLY DISINTEGRATING Full ProfileAll Drugs Causing ANXIETYAccord Healthcare, Inc. Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.